Vol 96, No 3 (2025)
Clinical vignette
Published online: 2024-11-14
ADAM 12 as a prognostic factor of pregnancy induced hypertension — preliminary study
Abstract
Not available
References
- Prejbisz A, Dobrowolski P, Kosiński P, et al. Management of hypertension in pregnancy: prevention, diagnosis, treatment and long‑term prognosis. Kardiol Pol. 2019; 77(7-8): 757–806.
- Mounier-Vehier C, Amar J, Boivin JM, et al. Hypertension and pregnancy: expert consensus statement from the French Society of Hypertension, an affiliate of the French Society of Cardiology. Fundam Clin Pharmacol. 2017; 31(1): 83–103.
- Luger RK, Kight BP. Hypertension In Pregnancy in StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing 2022: PMID: 28613589.
- Nyren-Erickson EK, Jones JM, Srivastava DK, et al. A disintegrin and metalloproteinase-12 (ADAM12): function, roles in disease progression, and clinical implications. Biochim Biophys Acta. 2013; 1830(10): 4445–4455.
- Moncada-Pazos A, Obaya AJ, Llamazares M, et al. ADAMTS-12 metalloprotease is necessary for normal inflammatory response. J Biol Chem. 2012; 287(47): 39554–39563.
- Wei J, Richbourgh B, Jia T, et al. ADAMTS-12: a multifaced metalloproteinase in arthritis and inflammation. Mediators Inflamm. 2014; 2014: 649718.
- Kasimis C, Evangelinakis N, Rotas M, et al. Predictive value of biochemical marker ADAM-12 at first trimester of pregnancy for hypertension and intrauterine growth restriction. Clin Exp Obstet Gynecol. 2016; 43(1): 43–47.
- Kasimis C, Evangelinakis N, Rotas M, et al. Predictive value of biochemical marker ADAM-12 at first trimester of pregnancy for hypertension and intrauterine growth restriction. Clin Exp Obstet Gynecol. 2016; 43(1): 43–47.
- Myers JE, Thomas G, Tuytten R, et al. Mid-trimester maternal ADAM12 levels differ according to fetal gender in pregnancies complicated by preeclampsia. Reprod Sci. 2015; 22(2): 235–241.
